DHDavid Horst

David Horst

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


David Horst has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Southeast Asian diversity: first insights into the complex mtDNA structure of Laos

    by Martin Bodner, Bettina Zimmermann, Alexander Röck, Anita Kloss-Brandstätter, David Horst, Basil Horst, Sourideth Sengchanh, Torpong Sanguansermsri, Jürgen Horst, Tanja Krämer, et al.

    Background: Vast migrations and subsequent assimilation processes have shaped the genetic composition of Southeast Asia, an area of close contact between several major ethnic groups. To better characterize the genetic variation of this region, we analyzed the entire mtDNA control region of 214 unrelated donors from Laos according to highest forensic quality standards. To detail the phylogeny, we inspected selected SNPs from the mtDNA coding region. For a posteriori data quality control, quasi-median network constructions and autosomal STR typing were performed. In order to describe the mtDNA setup of Laos more thoroughly, the data were subjected to population genetic comparisons with 16 East Asian groups. Results: The Laos sample exhibited ample mtDNA diversity, reflecting the huge number of ethnic groups listed. We found several new, so far undescribed mtDNA lineages in this dataset and surrounding populations. The Laos population was characteristic in terms of haplotype composition and genetic structure, however, genetic comparisons with other Southeast Asian populations revealed limited, but significant genetic differentiation. Notable differences in the maternal relationship to the major indigenous Southeast Asian ethnolinguistic groups were detected. Conclusions: In this study, we portray the great mtDNA variety of Laos for the first time. Our findings will contribute to clarify the migration history of the region. They encourage setting up regional and subpopulation databases, especially for forensic applications. The Laotian sequences will be incorporated into the collaborative EMPOP mtDNA database http://www.empop.org upon publication and will be available as the first mtDNA reference data for this country.


  • Open Access

    Invasion associated up‐regulation of nuclear factor κB target genes in colorectal cancer

    by David Horst, Jan Budczies, Thomas Brabletz, Thomas Kirchner, Falk Hlubek

    BACKGROUND: Colorectal cancer (CRC) displays intratumoral heterogeneity with less differentiated tumor cells at the invasive front (IF) than in the tumor center (TC). The authors previously observed that several genes were overexpressed at the IF of CRC with relations to inflammatory processes. Because nuclear factor κB (NF‐κB), a dimeric transcription factor, is a major regulator of such processes, and because its target genes are involved in immune response, cell growth control, and cell survival, the expression of NF‐κB target genes was investigated comparatively in CRC.METHODS: By using gene array profiling, NF‐κB target gene expression was assessed in CRCs that expressed human mutL homolog 1 (hMLH1), hMSH2, and nuclear β‐catenin by comparing expression at the IF, in the TC, and in normal mucosa. In addition, 5 NF‐κB target genes with high differential expression were validated by using immunohistochemistry.RESULTS: The expression of NF‐κB target genes in the TC, at the IF, and in normal mucosa was distinct; whereas, specifically at the IF, most differentially expressed NF‐κB targets were up‐regulated. Moreover, the results indicated that the expression diverged between epithelial tumor cells and inflammatory stromal cells.CONCLUSIONS: Because the results demonstrated that inflammation and the activation of NF‐κB signaling promoted CRC invasiveness, the current study provided further evidence that downstream targets of NF‐κB signaling may be specifically relevant in invasion and progression of CRC. Finally, as has been suggested for colitis‐associated cancer, the authors of this report concluded that the inhibition of NF‐κB signaling also may be an additional option for the treatment of sporadic CRC. Cancer 2009. © 2009 American Cancer Society.